Cardiac contractility modulation is a therapy which is intended for the treatment of patients with moderate to severe heart failure (NYHA class II–IV) with symptoms despite optimal medical …

2022年3月14日 · CCM therapy delivers nonexcitatory biphasic electric signals (7.5 V/22 ms duration) to the right ventricular septum during the absolute refractory period of the cardiac …

2018年12月10日 · Cardiac contractility modulation (CCM) is a device-based therapy for heart failure (HF) that involves applying relatively high-voltage (≈7.5 V), long-duration (≈20 …

2024年1月31日 · CCM is a device-based therapy to treat patients with symptomatic heart failure. “The goal of this device is to provide electrical impulses during a particular time of the cardiac …

Cardiac Contractility Modulation is a therapy which is intended for the treatment of patients with moderate to severe chronic heart failure (NYHA class III–IV), LVEF 25-45% and QRS <130ms …

In recent years, a new therapy—cardiac contractility modulation (CCM)—has become available. This therapy delivers high amplitude non-excitatory biphasic electrical signals during the …

Cardiac contractility modulation (CCM) has been shown to benefit patients with class III systolic heart failure with an ejection fraction of 25%–45% not indicated for biventricular pacing. …

Background: Cardiac contractility modulation (CCM) is a treatment option for patients suffering symptomatic chronic heart failure (CHF) with reduced left ventricular ejection fraction (LVEF) …

CCM delivers a biphasic high-voltage bipolar signal to the RV septum during the absolute refractory period, eliciting an acute increase in global contractility, and chronically producing a …

Cardiac contractility modulation (CCM) is a device-based therapy for heart failure (HF) that involves applying relatively high-voltage (≈7.5 V), long-dura-tion (≈20 milliseconds), biphasic …